Abstract
Bovine somatotropin with an increasing number of its carboxylate groups modified by reaction with glycine methyl ester in the presence of a water-soluble carbodi-imide was tested for its activity in different bioassays. Only those derivatives which were known to be active in the body-weight-increase bioassay were able to compete with 125I-labelled bovine somatotropin for their specific binding sites in vivo. No difference was found in the rate of clearance of a poorly active derivative as compared with that of native somatotropin. In contrast, both active and inactive derivatives were found to be equally effective in displacing the tracer from its binding sites present in isolated cells and membrane preparations from rat liver. These results suggest that the liver somatogenic receptors studied in vitro are less discriminating than those detected in vivo.
Full text
PDF





Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Baxter R. C., Bryson J. M., Turtle J. R. Somatogenic receptors of rat liver: regulation by insulin. Endocrinology. 1980 Oct;107(4):1176–1181. doi: 10.1210/endo-107-4-1176. [DOI] [PubMed] [Google Scholar]
- Berry M. N., Friend D. S. High-yield preparation of isolated rat liver parenchymal cells: a biochemical and fine structural study. J Cell Biol. 1969 Dec;43(3):506–520. doi: 10.1083/jcb.43.3.506. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bonifacino J. S., Roguin L. P., Paladini A. C. Formation of complexes between 125I-labelled human or bovine somatotropins and binding proteins in vivo in rat liver and kidney. Biochem J. 1983 Jul 15;214(1):121–132. doi: 10.1042/bj2140121. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bonifacino J. S., Sánchez S. H., Paladini A. C. Characterization of human somatotropin binding to detergent-solubilized lactogenic receptors from rat liver. Biochem J. 1981 Feb 15;194(2):385–394. doi: 10.1042/bj1940385. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cadman H. F., Wallis M. An investigation of sites that bind human somatotropin (growth hormone) in the liver of the pregnant rabbit. Biochem J. 1981 Sep 15;198(3):605–614. doi: 10.1042/bj1980605. [DOI] [PMC free article] [PubMed] [Google Scholar]
- DELLACHA J. M., SONENBERG M. PURIFICATION OF BOVINE GROWTH HORMONE. J Biol Chem. 1964 May;239:1515–1520. [PubMed] [Google Scholar]
- Delfino J. M., Fernandez H. N., Santomé J. A. Specific modification of carboxyl-groups in bovine growth hormone by a soluble carbodiimide and glycinemethylester. Int J Pept Protein Res. 1983 Apr;21(4):440–450. doi: 10.1111/j.1399-3011.1983.tb03125.x. [DOI] [PubMed] [Google Scholar]
- Dufau M. L., Catt K. J., Tsuruhara T. Retention of in vitro biological activities by desialylated human luteinizing hormone and chorionic gonadotropin. Biochem Biophys Res Commun. 1971 Sep;44(5):1022–1029. doi: 10.1016/s0006-291x(71)80188-2. [DOI] [PubMed] [Google Scholar]
- Etzrodt H., Musch K. A., Schleyer M., Pfeiffer E. F. Growth hormone radiologand assay unresponsive to human prolactin. J Clin Endocrinol Metab. 1976 Jun;42(6):1184–1187. doi: 10.1210/jcem-42-6-1184. [DOI] [PubMed] [Google Scholar]
- Fix J. A., Leppert P., Moore W. V. Growth hormone and prolactin binding to rabbit liver plasma membranes. Horm Metab Res. 1981 Sep;13(9):510–515. doi: 10.1055/s-2007-1019319. [DOI] [PubMed] [Google Scholar]
- GREENWOOD F. C., HUNTER W. M., GLOVER J. S. THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY. Biochem J. 1963 Oct;89:114–123. doi: 10.1042/bj0890114. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hughes J. P. Identification and characterization of high and low affinity binding sites for growth hormone in rabbit liver. Endocrinology. 1979 Aug;105(2):414–420. doi: 10.1210/endo-105-2-414. [DOI] [PubMed] [Google Scholar]
- Kyle C. V., Evans M. C., Odell W. D. Optimization of a radioreceptor assay for human growth hormone using male rat liver membranes. Proc Soc Exp Biol Med. 1982 Mar;169(3):368–375. doi: 10.3181/00379727-169-41359. [DOI] [PubMed] [Google Scholar]
- Peña C., Poskus E., Paladini A. C. A relevant antigenic site in human growth hormone localized in sequence 98-128. Mol Immunol. 1980 Dec;17(12):1487–1491. doi: 10.1016/0161-5890(80)90174-1. [DOI] [PubMed] [Google Scholar]
- Poskus E., Zakin M. M., Fernámdez H. N., Paladini A. C. Detection of immunologically active zones in equine growth hormone. Eur J Immunol. 1976 Jun;6(6):409–417. doi: 10.1002/eji.1830060607. [DOI] [PubMed] [Google Scholar]
- Posner B. I., Kelly P. A., Shiu R. P., Friesen H. G. Studies of insulin, growth hormone and prolactin binding: tissue distribution, species variation and characterization. Endocrinology. 1974 Aug;95(2):521–531. doi: 10.1210/endo-95-2-521. [DOI] [PubMed] [Google Scholar]
- Postel-Vinay M. C. Binding of human growth hormone to rat liver membranes: lactogenic and somatotropic sties. FEBS Lett. 1976 Oct 15;69(1):137–140. doi: 10.1016/0014-5793(76)80670-9. [DOI] [PubMed] [Google Scholar]
- Postel-Vinay M. C., Desbuquois B. Interaction of human growth hormone with isolated rat liver cells. Endocrinology. 1977 Jan;100(1):209–215. doi: 10.1210/endo-100-1-209. [DOI] [PubMed] [Google Scholar]
- Ranke M. B., Stanley C. A., Rodbard D., Baker L., Bongiovanni A., Parks J. S. Sex differences in binding of human growth hormone to isolated rat hepatocytes. Proc Natl Acad Sci U S A. 1976 Mar;73(3):847–851. doi: 10.1073/pnas.73.3.847. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ranke M. B., Stanley C. A., Tenore A., Rodbard D., Bongiovanni A. M., Parks J. S. Characterization of somatogenic and lactogenic binding sites in isolated rat hepatocytes. Endocrinology. 1976 Oct;99(4):1033–1045. doi: 10.1210/endo-99-4-1033. [DOI] [PubMed] [Google Scholar]
- Roth J. Methods for assessing immunologic and biologic properties of iodinated peptide hormones. Methods Enzymol. 1975;37:223–233. doi: 10.1016/s0076-6879(75)37018-3. [DOI] [PubMed] [Google Scholar]
- Tsuruhara T., Dufau M. L., Hickman J., Catt K. J. Biological properties of hCG after removal of terminal sialic acid and galactose residues. Endocrinology. 1972 Jul;91(1):296–301. doi: 10.1210/endo-91-1-296. [DOI] [PubMed] [Google Scholar]
- Tsuruhara T., Van Hall E. V., Dufau M. L., Catt K. J. Ovarian binding of intact and desialytated hcg in vivo and in vitro. Endocrinology. 1972 Aug;91(2):463–469. doi: 10.1210/endo-91-2-463. [DOI] [PubMed] [Google Scholar]
- Tsushima T., Friesen H. G. Radioreceptor assay for growth hormone. J Clin Endocrinol Metab. 1973 Aug;37(2):334–337. doi: 10.1210/jcem-37-2-334. [DOI] [PubMed] [Google Scholar]
- Turyn D., Dellacha J. M. Specific binding of iodinated growth hormone to rat liver in vivo. Endocrinology. 1978 Oct;103(4):1190–1195. doi: 10.1210/endo-103-4-1190. [DOI] [PubMed] [Google Scholar]
- Turyn D., Santomé J. A., Dellacha J. M., Stringa de Muzzio I. G., Domergasso C. S. Specific binding of human and bovine growth hormones to hypophysectomized rat hepatocytes. Acta Physiol Lat Am. 1976;26(5):395–402. [PubMed] [Google Scholar]
- Van Hall E. V., Vaitukaitis J. L., Ross G. T., Hickman J. W., Ashwell G. Effects of progressive desialylation on the rate of disappearance of immunoreactive HCG from plasma in rats. Endocrinology. 1971 Jul;89(1):11–15. doi: 10.1210/endo-89-1-11. [DOI] [PubMed] [Google Scholar]
- Van Hall E. V., Vaitukaitis J. L., Ross G. T., Hickman J. W., Ashwell G. Immunological and biological activity of HCG following progressive desialylation. Endocrinology. 1971 Feb;88(2):456–464. doi: 10.1210/endo-88-2-456. [DOI] [PubMed] [Google Scholar]
